Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate)) is a Highly Potent and Selective MEK Inhibitor that specifically inhibits MEK1/2(IC50 :2 nM)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 41.00 | |
25 mg | In stock | $ 54.00 | |
50 mg | In stock | $ 57.00 | |
100 mg | In stock | $ 82.00 | |
200 mg | In stock | $ 117.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate)) is a Highly Potent and Selective MEK Inhibitor that specifically inhibits MEK1/2(IC50 :2 nM) |
Targets&IC50 | MEK1/2:2 nM |
In vitro | Trametinib DMSO solvate displays remarkable potency in cellular assays for ERK1/2 phosphorylation and growth inhibition and excellent in vivo activity.?Inhibition of the MEK?ERK pathway offers a very promising therapeutic strategy for cancers with activating mutant Ras and Raf, and GSK1120212 (DMSO solvate) has been advanced into phase III trials for advanced or metastatic BRAF mutant melanoma as well as phase I and II studies in subjects with solid tumors or leukemia. |
In vivo | Trametinib DMSO solvate was then evaluated in vivo in an A549 (KRAS mutant cell line) xenograft model, orally dosing daily for 21 days (qd × 21).Near complete tumor growth inhibition was observed at 5.0 and 2.5 mg/kg [92 and 87% tumor growth inhibition (TGI), respectively] and to a lesser degree at 0.5 and 0.1 mg/kg (62 and 58% TGI).?[Notably, although 5 mg/kg was the maximally tolerated dose (MTD) , 3 mg/kg is the typically observed MTD.] Dose-dependent antitumor activity with GSK1120212 (DMSO solvate) treatment has been similarly reported for several other KRAS and BRAF mutant tumor models. |
Synonyms | Trametinib DMSO solvate, GSK-1120212 (DMSO solvate), Trametinib dimethyl sulfoxide, JTP-74057 (DMSO solvate) |
Molecular Weight | 693.53 |
Formula | C28H29FIN5O5S |
CAS No. | 1187431-43-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 69 mg/mL (99.49 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Trametinib (DMSO solvate) 1187431-43-1 Apoptosis MAPK MEK Mitogen-activated protein kinase kinase GSK 1120212 JTP 74057 arthritis JTP74057 MAPKK inhibit DMSO solvate Adjuvant-induced orally Trametinib DMSO solvate Inhibitor JTP-74057 GSK-1120212 (DMSO solvate) CIA Trametinib dimethyl sulfoxide JTP-74057 (DMSO solvate) GSK1120212 type collageninduced GSK-1120212 AIA Trametinib MAP2K inhibitor